Dag-uman, Sofia Marienela A.

HRN: 22-11-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/24/2022
10/31/2022
IVTT
2.1g
Q8
SEPSIS
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: